Evidence map›Paper›PMID 29463038›Full record

ArticleInternational journal of molecular sciences2018

Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid Liposarcomas.

Monica S Ventura Ferreira, Martina Crysandt, Till Braunschweig, Edgar Jost, Barbara Voss, Anne-Sophie Bouillon, Ruth Knuechel, Tim H Brümmendorf, Fabian Beier

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Telomeres and telomerase in Sarcoma disease and therapy.International journal of medical sciences · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Spindle cell liposarcoma with a TRIO-TERT fusion transcript.Virchows Archiv : an international journal of pathology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Monica S Ventura FerreiraDepartment of Hematology, Oncology, Haemostaseology and Stem Cell Transplantation, RWTH Aachen University Medical Faculty, 52074 Aachen, Germany. mventuraferreira@ukaachen.de.ORCID 0000-0002-1437-1342
Martina CrysandtDepartment of Hematology, Oncology, Haemostaseology and Stem Cell Transplantation, RWTH Aachen University Medical Faculty, 52074 Aachen, Germany. mcrysandt@ukaachen.de.
Till BraunschweigInstitute of Pathology, RWTH Aachen University Medical Faculty, 52074 Aachen, Germany. tbraunschweig@ukaachen.de.
Edgar JostDepartment of Hematology, Oncology, Haemostaseology and Stem Cell Transplantation, RWTH Aachen University Medical Faculty, 52074 Aachen, Germany. ejost@ukaachen.de.
Barbara VossDepartment of Hematology, Oncology, Haemostaseology and Stem Cell Transplantation, RWTH Aachen University Medical Faculty, 52074 Aachen, Germany. bavoss@ukaachen.de.
Anne-Sophie BouillonDepartment of Hematology, Oncology, Haemostaseology and Stem Cell Transplantation, RWTH Aachen University Medical Faculty, 52074 Aachen, Germany. abouillon@ukaachen.de.
Ruth KnuechelInstitute of Pathology, RWTH Aachen University Medical Faculty, 52074 Aachen, Germany. rknuechel-clarke@ukaachen.de.
Tim H BrümmendorfDepartment of Hematology, Oncology, Haemostaseology and Stem Cell Transplantation, RWTH Aachen University Medical Faculty, 52074 Aachen, Germany. tbruemmendorf@ukaachen.de.
Fabian BeierDepartment of Hematology, Oncology, Haemostaseology and Stem Cell Transplantation, RWTH Aachen University Medical Faculty, 52074 Aachen, Germany. fbeier@ukaachen.de.
RWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The occurrence of

Indexed as

Promoter Regions, GeneticBase SequenceBone NeoplasmsFemaleHumansIn Situ Hybridization, FluorescenceLiposarcoma, MyxoidMaleMiddle AgedMutationNeoplasm GradingSarcomaTelomeraseTelomereTelomeraseTERT protein, humanmyxoid liposarcomasarcomatelomerasetelomereTERT promoter mutation

Identifiers

PMID29463038
PMCPMC5855830
OpenAlexW2790638908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.